论文部分内容阅读
１９９７年８月至１９９８年１０月应用沈阳协和集团生产的高聚生（高聚金葡素）与化疗联合应用治疗晚期原发性肝癌４０例，与同期单纯化疗３８例患者进行对比，观察瘤体、腹水、生活质量、白细胞计数、肝肾功能、免疫功能及生存率，取得比较满意的效果，现报告如下。１材料与
From August 1997 to October 1998, 40 patients with advanced primary hepatocellular carcinoma were treated with the combination of hypercoagulation and chemotherapy of Shenyang Union Pharmaceuticals Group, compared with 38 patients with chemotherapy alone in the same period. The tumor, Ascites, quality of life, white blood cell count, liver and kidney function, immune function and survival rate, to obtain more satisfactory results, are as follows. 1 material and